{
  "AtrialFibrillation": {
    "summary": {
      "afStage": {
        "stage": "Paroxysmal Atrial Fibrillation",
        "evidence": "Diagnosis of Paroxysmal Atrial Fibrillation in patient data",
        "reference": "Table 1: Recommendations for the diagnosis of AF"
      },
      "cha2ds2VaScore": {
        "score": "Unknown",
        "keyContributingFactors": [],
        "riskLevel": "Unknown",
        "reference": "Table 10: Updated definitions for the CHA₂DS₂-VA score"
      },
      "Summary_and_Clinical_Considerations": [
        {
          "summary": "78-year-old male patient with Paroxysmal Atrial Fibrillation, systolic blood pressure 141 mmHg, diastolic blood pressure 64 mmHg, pulse 71 minutes, haemoglobin 14 g/dL, and total cholesterol 3.7 mmol/L",
          "clinicalConsiderations": [
            "The patient's diagnosis of Paroxysmal Atrial Fibrillation requires further evaluation and management to prevent stroke and thromboembolism"
          ]
        }
      ],
      "missingData": [
        {
          "data": "ECG results",
          "actionableOrder": "Order an electrocardiogram (ECG) to confirm the diagnosis of AF"
        },
        {
          "data": "CHA₂DS₂-VA score components (e.g., congestive heart failure, hypertension, age, diabetes, stroke, vascular disease, sex category)",
          "actionableOrder": "Gather patient history and perform physical examination to assess CHA₂DS₂-VA score components"
        }
      ],
      "recommendations": [
        {
          "section": "Immediate Considerations",
          "items": [
            "Confirm the diagnosis of AF with an electrocardiogram (ECG)"
          ],
          "reference": "Table 1: Recommendations for the diagnosis of AF"
        },
        {
          "section": "Further Evaluation Needed",
          "items": [
            "Assess CHA₂DS₂-VA score components to determine stroke risk"
          ],
          "reference": "Table 10: Updated definitions for the CHA₂DS₂-VA score"
        },
        {
          "section": "Long Term Management",
          "items": [
            "Consider anticoagulation therapy to prevent stroke and thromboembolism"
          ],
          "reference": "Table 20: Recommendations for anticoagulation in patients undergoing catheter"
        }
      ]
    },
    "radiologyOrders": [
      {
        "orderCodeDescription": "93306 - Transthoracic echocardiogram",
        "purpose": "Evaluate cardiac structure and function to guide treatment decisions",
        "evidence": "Patient diagnosed with Paroxysmal Atrial Fibrillation",
        "reference": "Table 3: Recommendations for diagnostic evaluation in patients with new AF"
      }
    ],
    "laboratoryOrders": [
      {
        "orderCodeDescription": "83540 - D-dimer",
        "purpose": "Assess thromboembolic risk",
        "evidence": "Patient diagnosed with Paroxysmal Atrial Fibrillation",
        "reference": "Table 20: Recommendations for anticoagulation in patients undergoing catheter"
      },
      {
        "orderCodeDescription": "84443 - Creatinine",
        "purpose": "Assess renal function to guide anticoagulation therapy",
        "evidence": "Patient diagnosed with Paroxysmal Atrial Fibrillation",
        "reference": "Table 20: Recommendations for anticoagulation in patients undergoing catheter"
      }
    ],
    "medications": [
      {
        "orderCodeDescription": "NDC 0002-4113-10 - Apixaban 5mg",
        "doseFrequency": "5mg twice daily",
        "purpose": "Anticoagulation to prevent stroke and thromboembolism",
        "evidence": "Patient diagnosed with Paroxysmal Atrial Fibrillation and elevated thromboembolic risk",
        "reference": "Table 20: Recommendations for anticoagulation in patients undergoing catheter"
      }
    ]
  }
}
